As of 4:00pm ET
| +0.01 / +0.49%|
The 3 analysts offering 12-month price forecasts for Cytori Therapeutics Inc have a median target of 6.00, with a high estimate of 11.00 and a low estimate of 5.00. The median estimate represents a +191.26% increase from the last price of 2.06.
The current consensus among 3 polled investment analysts is to Buy stock in Cytori Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.